News
-
October 23, 2013 | Scion Medical Technologies Receives ISO 13485 Certification
Newton, MA- Scion Medical Limited was awarded ISO 13485 certification both for its China manufacturing facility in Taizhou, China and for its US subsidiary, Scion Medical Technologies LLC. ISO 13485 is an internationally recognized quality standard for medical devices. ISO 13485 represents the requirements for a comprehensive quality management system for the design and manufacture of medical devices. It demonstrates Scion’s commitment for quality throughout the product development life-cycle and the product’s lifespan with customers. Obtaining the ISO
More... -
August 1, 2013 | Scion Medical Technologies Receives CE Mark Clearance for Cassi Breast Biopsy System
Newton, MA- Scion Medical Technologies, LLC. has received CE Mark (Conformité Européenne) designation for the Cassi breast biopsy system. The CE Mark paves the way for the Cassi breast biopsy system to be offered to the European market. About Scion Medical Technologies Scion Medical Technologies (Scion) is a global medical device company with US headquarters in Massachusetts. Scion has manufacturing, distribution and regulatory expertise in the US and China, and is actively looking to grow its product portfolio
More... -
May 10, 2013 |Scion Medical Technologies receives FDA 510 (k) clearance for the Cassi™ Beacon™ tissue marker
Newton, MA - Scion Medical Technologies, LLC announces the introduction of the Cassi™ Beacon™ tissue marker, the company’s newest addition to the Cassi™ breast biopsy product portfolio. The Cassi Beacon tissue marker is a single use marker which is placed into soft tissue during breast biopsy procedures to radiographically mark a surgical site for easy location during a surgical procedure or for future procedures. The marker provides excellent and permanent visualization under the major imaging modalities;
More... -
December 19, 2012 | Scion Medical Limited Acquired B. Braun VascuFlex® Family of Products
December 19, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC, announced today that it parent company Scion Medical Limited has acquired a portfolio of peripheral interventional radiology products, including 36 global patents, from B. Braun. The portfolio consists of the VascuFlex® family of stent products currently marketed globally, a distal protection device and an embolization product in late stage development. The VascuFlex® product family has regulatory clearance and is currently marketed in over
More... -
June 26, 2012 | Scion Acquires Soft Tissue Marker with FDA Marketing Clearance from Kent Medical Devices, Inc.
June 26, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC (Scion), a company that manufactures and sells products in the general surgery area, announced today that it has acquired a soft tissue marker product line with FDA marketing clearance from Kent Medical Devices, Inc. of Minneapolis, Minnesota. "The Kent Medical Devices soft tissue marker product line bolsters our growing portfolio of biopsy products. The Kent tissue marker was designed for improved visibility under ultrasound imaging, while also
More... -
June 15, 2012 | Scion Acquires Soft Tissue Biopsy Product Line
June 15, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC (Scion), a company that manufactures and sells products in the general surgery area, announced today that it has acquired a suite of assets for soft tissue biopsy, including issued intellectual property for a novel approach in the field. Scion is completing the final stages of development of the product and plans to submit a 510(k) toward the end of the calendar year. This product line will
More... -
April 26, 2012 | Scion Co-Sponsors Cassi II™ Breast Biopsy Device Ultrasound Training for Chinese Physicians
During the week of Monday, April 30 - Saturday, May 5, 2012, seven physicians from China will train with internationally distinguished interventional radiologist Ken Tomkovich, MD, director of breast imaging and interventional radiology at CentraState Medical Center and affiliated with Freehold Radiology Group. The training will cover the latest imaging and interventional radiology procedures for diagnosing breast cancer, including ultrasound training for Scion's Cassi II™ breast biopsy device. The training program at CentraState is funded
More... -
November 21, 2011 | Scion Hosts Symposium: Medical Devices in the Emerging Chinese Market
November 21, 2011 – Waltham, Massachusetts. Scion Medical Technologies co-hosted the symposium, "Medical Devices in the Emerging Chinese Market". Scion and its co-host, CMC Group, the investment arm of China Medical City, a government backed life sciences economic zone in Taizhou, China, brought together a panel of leading medical device industry experts from the U.S. and China to discuss the business and regulatory climate for medical devices in the Chinese market. Panel members included officers
More... -
October 20, 2011 | Scion Acquires Cassi II Breat Biopsy Product from Sanarus Technologies, LLC
October 20, 2011 – Newton, Massachusetts. Scion Medical Technologies, LLC (Scion), a company that manufactures and sells products in the general surgery area, announced today that it has acquired the Cassi II™ line of breast biopsy products from Sanarus Technologies, LLC of Pleasanton, California. “We are extremely excited to add Cassi II to our product portfolio,” said Scion’s CEO Joseph Siletto. “Cassi II is a truly unique, elegantly designed, reliable product for breast biopsy that we
More... -
September 12, 2011 | David Jacobs Named Vice President of Engineering and Operations
September 12, 2011 – Newton, Massachusetts. David Jacobs joined Scion Medical Technologies™ (Scion) as Vice President of Engineering and Operations. Mr. Jacobs will oversee global engineering and manufacturing operations for the company, including the Company’s manufacturing facility in Taizhou, China. “We are thrilled that Dave is joining our team,” said Scion CEO Joseph Siletto. “Dave has a wealth of experience in the medical device industry and brings an invaluable skill set to our company as we
More...